Product Program year 2023 Source: CMS Open Payments

Purixan

Drug Oncology

Open in the dashboard

General payments

$1,549

55 payments

Research payments

$0

0 payments

Through program year 2023, $1,549 in general payments and $0 in research payments were reported against Purixan (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2023 General $714 38
2022 General $98 4
2021 General $393 10
2020 General $344 3

Breakdown

Who paid General payments · program years 2020–2023
  1. Rare Disease Therapeutics, Inc. $1,549 55 payments
Top recipients General payments · program year 2023
  1. Lucy Paskus Nurse Practitioner, Pediatrics · Indianapolis, IN $48 7% · 1 payment
  2. Jessica Mollabashy Nurse Practitioner, Pediatrics · Indianapolis, IN $48 7% · 1 payment
  3. Bassem Razzouk Pediatric Hematology-Oncology · Indianapolis, IN $48 7% · 1 payment
  4. Kiley Mattox Nurse Practitioner, Pediatrics · Indianapolis, IN $23 3% · 1 payment
  5. Susmita Sarangi Pediatric Hematology-Oncology · Washington, DC $23 3% · 1 payment

The top 5 of 38 recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Pediatric Hematology-Oncology Pediatrics $345 48% · 17 practitioners
  2. Nurse Practitioner, Pediatrics Nurse Practitioner $246 34% · 11 practitioners
  3. Physician Assistant, Medical Physician Assistant $44 6% · 2 practitioners
  4. Nurse Practitioner $38 5% · 3 practitioners
  5. Physician Assistant $23 3% · 2 practitioners

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. New York $198 28% · 11 recipients
  2. Indiana $166 23% · 4 recipients
  3. Colorado $156 22% · 7 recipients
  4. District of Columbia $68 10% · 3 recipients
  5. Texas $34 5% · 3 recipients

The top 5 of 10 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

55 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record